SUMMARY Ten patients (8 female, 2 male) with systemic lupus erythematosus (SLE) were entered into an open trial with the anabolic steroid 19-nortestosterone (19-nor 
titative differences between the female and male immunological systems, which may in part at least be determined by the sex hormones.23 The NZB/NZW Fl hybrid mouse (B/W) develops an illness similar to that of human systemic lupus erythematosus (SLE) and has provided a model for investigating the disease. There is earlier mortality in the female mouse, although prepubertal castration of male mice increases their premature death rate. 4 Androgens administered early or late in life to prepubertally castrated mice are effective in suppressing disease activity. 5 6 The anabolic steroid 19-nortestosterone (nandrolone) and its decanoate ester have also produced significant amelioration of disease in the B/W mouse, indicating that the therapeutic phenomenon might be distinct from the androgenic properties of steroids. 7 Since there was experimental evidence for the efficacy of nandrolone (Decadurabolin) 
Results
The mean duration of treatment was a little over 6 months with an average total dose of 800 mg of nandrolone decanoate. 155 Seven of the 10 patients had Ty cell levels which were outside the normal range. Five of these were depressed, while 2 were elevated. One remained high, but the remainder returned to normal or stayed within the normal range after the first 3 months of treatment. T,u cell levels remained largely unchanged throughout the period of observation (Table 2 ). Concanavalin-A-induced suppressor cell activity showed no significant change and remained constant, slightly below the levels found in healthy adults at 84 + 19 (SD)%.
Discussion
Overall, patients in this open trial did not benefit from 19-nor. Indeed they may have worsened clinically, although it is difficult to be certain, as one observation period may not reflect the number and severity of exacerbations in another.
Other authors reported very low levels for Ty cells (reputed to contain suppressor activity) in SLE13 or in some cases both high and low levels"4; so the link with SLE is not absolute. T,u cells (thought to contain T helper activity) were largely unchanged and did not differ significantly from those of normal control subjects. The levels found in this study accord with those of other studies.13
The changes in Ty cell population were not accompanied by any increase in the level of concanavalin-A-inducible suppressor activity which might be expected to be the route by which autoimmune reac- 
